RGFP 966

CAS No. 1357389-11-7

RGFP 966( RGFP966 | RGFP 966 | RGFP-966 )

Catalog No. M11466 CAS No. 1357389-11-7

RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 65 In Stock
10MG 102 In Stock
25MG 178 In Stock
50MG 282 In Stock
100MG 462 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RGFP 966
  • Note
    Research use only, not for human use.
  • Brief Description
    RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.
  • Description
    RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RGFP966 | RGFP 966 | RGFP-966
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1357389-11-7
  • Formula Weight
    362.4
  • Molecular Formula
    C21H19FN4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥100mM
  • SMILES
    O=C(NC1=CC=C(F)C=C1N)/C=C/C2=CN(C/C=C/C3=CC=CC=C3)N=C2.
  • Chemical Name
    (E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Malvaez M, et al. PNAS, 2013, 110(7), 2647-2652.
molnova catalog
related products
  • Belinostat

    A potent HDAC inhibitor with IC50 of 27 nM.

  • T326

    A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.

  • SIS17

    SIS17 is a potent and selective HDAC 11 inhibitor with an IC50 value of 0.83 μM. SIS17 is active in cells and inhibited the demyristoylation of a known HDAC11 substrate serine hydroxymethyl transferase 2 without inhibiting other HDACs.